Avantor (NYSE:AVTR) PT Lowered to $26.00

Avantor (NYSE:AVTR) had its price target decreased by analysts at Robert W. Baird from $27.00 to $26.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s target price indicates a potential upside of 7.30% from the company’s current price.

Other equities research analysts have also recently issued reports about the company. Citigroup upped their price target on Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. JPMorgan Chase & Co. upped their price target on Avantor from $26.00 to $29.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Raymond James boosted their price objective on Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a report on Friday, January 26th. Deutsche Bank Aktiengesellschaft boosted their price objective on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Thursday, April 18th. Finally, Evercore ISI boosted their price objective on Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $26.71.

Avantor Trading Up 0.6 %

Shares of Avantor stock opened at $24.23 on Monday. Avantor has a 52-week low of $16.63 and a 52-week high of $26.16. The stock’s 50-day simple moving average is $25.09 and its 200 day simple moving average is $22.68. The stock has a market capitalization of $16.43 billion, a P/E ratio of 62.13, a P/E/G ratio of 2.44 and a beta of 1.37. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.05 and a current ratio of 1.61.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.02. Avantor had a return on equity of 13.15% and a net margin of 3.79%. The business had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the previous year, the business posted $0.29 EPS. The firm’s quarterly revenue was down 5.6% compared to the same quarter last year. As a group, research analysts anticipate that Avantor will post 1.01 EPS for the current year.

Insider Activity

In related news, EVP James Bramwell sold 6,203 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the completion of the transaction, the executive vice president now owns 101,143 shares in the company, valued at $2,476,992.07. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 1.30% of the company’s stock.

Hedge Funds Weigh In On Avantor

A number of hedge funds and other institutional investors have recently made changes to their positions in AVTR. Fifth Third Bancorp raised its holdings in Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after purchasing an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in Avantor by 565.5% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock worth $30,000 after purchasing an additional 1,131 shares in the last quarter. Gladius Capital Management LP bought a new position in Avantor in the fourth quarter worth $42,000. Montag A & Associates Inc. bought a new position in Avantor in the fourth quarter worth $43,000. Finally, TFO Wealth Partners LLC raised its holdings in Avantor by 203,100.0% in the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock worth $46,000 after purchasing an additional 2,031 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.